Penetrability of interleukin-1β and its effect on the concentration of tumor necrosis factor-α and interleukin-6 in the aqueous humor of rabbits treated with interleukin-1β

被引:1
|
作者
Peng Xiao-yan [1 ]
Chen Feng-hua [1 ]
Wang Ning-li [1 ]
Ma Jian-min [1 ]
Lee, Ping-yu [1 ,2 ]
Liu Ke-gao [1 ]
Podos, Steven M. [2 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing 100730, Peoples R China
[2] NYU, Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA
基金
中国国家自然科学基金;
关键词
interleukin-1; beta; tumor necrosis factor-alpha; intraocular pressure; rabbit; UVEOSCLERAL OUTFLOW PATHWAY; TRABECULAR MESHWORK CELLS; GLAUCOMATOUS MONKEY EYES; MATRIX METALLOPROTEINASES; LASER TRABECULOPLASTY; EXTRACELLULAR-MATRIX; CILIARY MUSCLE; PROSTAGLANDINS; LATANOPROST; EXPRESSION;
D O I
10.3760/cma.j.issn.0366-6999.2009.18.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Interleukin (IL)-1 beta may effectively decrease introcular pressure (IOP) when administered by subconjunctival injection in normal rabbit. However, IL-1 beta is a large molecular agent and an inflammation factor. The aim of this study was to evaluate the penetrability of IL-1 beta, and the concentrations of both tumor necrosis factor (TNF)-alpha and IL-6 in the aqueous humor of normal rabbits treated with IL-1 beta. Methods A total of 170 rabbits were used in the study and were assigned to several different treatment groups as follows: 125 of the rabbits were assigned to two groups. In one group, 33 rabbits were injected subconjunctivally with IL-1 beta and 39 were injected with saline alone. In the other group, 27 rabbits were given eye drops containing IL-1 beta (400 ng/ml) and 26 were given saline alone. Aqueous humor (AH) was drawn and the concentration of IL-1 beta within the fluid measured. The IOP was measured in another six rabbits after administration of eye drops containing IL-1 beta (400 ng/ml). A further 20 rabbits were assigned to 3 groups as follows: eight untreated normal controls; six injected subconjunctivally with IL-1 beta; and six injected subconjunctivally with saline alone. AH was drawn and the concentration of TNF-alpha in the fluid was measured. Another 19 rabbits were assigned to 3 groups as follows: seven untreated normal controls; and six injected subconjunctivally with IL-1 beta; and six injected subconjunctivally with saline alone. AH was drawn and the concentration of IL-6 in the fluid measured. Measurement of cytokine concentration was by radio-immunoassay in all cases. Results The IL-1 beta concentration in the AH was higher in those animals in which it had been administered subconjunctivally (P <0.01). The IL-1 beta concentration in the AH of the animals given eye drops was almost the same as that in the controls (P >0.05). The administration of IL-1 beta in the form of eye drops had little effect upon IOP reduction. Lower TNF-alpha concentrations were seen in the AH after the subconjunctival administration of IL-1 beta, but the concentration of IL-6 was the same as in the normal controls. Conclusions IL-1 beta shows good corneal penetrability after subconjunctival injection into normal rabbit eyes. The IOP reduction induced by IL-1 beta is unlikely be associated with an inflammatory response. Chin Med J 2009;122(18):2165-2168
引用
收藏
页码:2165 / 2168
页数:4
相关论文
共 50 条
  • [31] Gonadotropins induce the release of interleukin-1β, interleukin-6 and tumor necrosis factor-α from the human preovulatory follicle
    de Mola, JRL
    Goldfarb, JM
    Hecht, BR
    Baumgardner, GP
    Babbo, CJ
    Friedlander, MA
    [J]. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1998, 39 (06) : 387 - 390
  • [32] Influence of hemodialysis membrane on gene expression and plasma levels of interleukin-1β,tumor necrosis factor-α and interleukin-6
    余志远
    钱家麒
    陈诗书
    程枫
    张庆怡
    黄佩文
    戴慧莉
    [J]. 中华医学杂志(英文版), 1998, (08) : 13 - 13
  • [33] Synergistic Effects of Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α: Central Monoamine, Corticosterone, and Behavioral Variations
    Karen Brebner
    Shawn Hayley
    Robert Zacharko
    Zul Merali
    Hymie Anisman
    [J]. Neuropsychopharmacology, 2000, 22 : 566 - 580
  • [34] Interleukin-1β, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-α in chronic sinusitis:: Response to systemic corticosteroids
    Lennard, CM
    Mann, EA
    Sun, LL
    Chang, AS
    Bolger, WE
    [J]. AMERICAN JOURNAL OF RHINOLOGY, 2000, 14 (06): : 367 - 373
  • [35] The effects of tumor necrosis factor-α, interleukin-1β, interleukin-6, and transforming growth factor-β1 on pulp fibroblast mediated collagen degradation
    Wisithphrom, Kessiri
    Windsor, L. Jack
    [J]. JOURNAL OF ENDODONTICS, 2006, 32 (09) : 853 - 861
  • [36] Interleukin-1β, Interleukin-6 and Tumour Necrosis Factor-α Expression on Equine Endometrium determined by Immunohistochemistry
    del Alamo, M. M. Rivera
    Reine, E.
    Reilas, T.
    Rodriguez-Gil, J. E.
    Fernandez-Novell, J. M.
    Ballester, J.
    Katila, T.
    [J]. REPRODUCTION IN DOMESTIC ANIMALS, 2009, 44 : 122 - 122
  • [37] Evaluation of interleukin-6, tumour necrosis factor-α and interleukin-1β for early diagnosis of neonatal sepsis
    Silveira, RC
    Procianoy, RS
    [J]. ACTA PAEDIATRICA, 1999, 88 (06) : 647 - 650
  • [38] Complement factor I is upregulated in rat hepatocytes by interleukin-6 but not by interferon-γ, interleukin-1β or tumor necrosis factor-α
    Schlaf, G
    Demberg, T
    Koleva, M
    Jungermann, K
    Götze, O
    [J]. BIOLOGICAL CHEMISTRY, 2001, 382 (07) : 1089 - 1094
  • [39] TUMOR-NECROSIS-FACTOR, INTERLEUKIN-1, AND INTERLEUKIN-6 IN NORMAL HUMAN-PREGNANCY
    OPSJON, SL
    WATHEN, NC
    TINGULSTAD, S
    WIEDSWANG, G
    SUNDAN, A
    WAAGE, A
    AUSTGULEN, R
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (02) : 397 - 404
  • [40] Interleukin-1β, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-α levels in CSF and serum in relation to the clinical diversity of Parkinson's disease
    Karpenko, M. N.
    Vasilishina, A. A.
    Gromova, E. A.
    Muruzheva, Z. M.
    Bernadotte, A.
    [J]. CELLULAR IMMUNOLOGY, 2018, 327 : 77 - 82